Skip to content

Comparision of two drugs for maintaining blood pressure during surgeries of nose

A randomised double-blinded comparison of dexmedetomidine and magnesium sulphate for controlled hypotension in FESS - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070410
Enrollment
60
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Comparison between one alpha 2 agonist drug and one sulfate drug: A randomised double-blinded comparison of dexmedetomidine and magnesium sulphate for controlled hypotension in FESS Con

Sponsors

Vinayaka Missions Kirupananda Variyar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient posted for FESS under GA with: 1. ASA grade 1 and 2 2. Age between 18-60 years 3. Patient giving valid informed consent

Exclusion criteria

Exclusion criteria: 1. Patient Refusal 2. Age less than 18 years and more than 60 years 3. ASA Grade 3 and 4 4. Chronic Hypertension 5. Sinus Bradycardia 6. Hypotension 7. Anticipated Difficult Airway 8. General Hematological And Neuromuscular Disorder 9. Neuropathy

Design outcomes

Primary

MeasureTime frame
To evaluate the time to achieve the target mean arterial pressure with infusion doses of study drugTimepoint: 15 minutes post intubation to 15 minutes prior extubation

Secondary

MeasureTime frame
to assess the quality of the surgical field, adverse effects and recovery characteristics in patients undergoing FESS under general anaesthesiaTimepoint: 15 minutes after intubation upto 2 hours post surgery

Countries

India

Contacts

Public ContactDr Kiran Reddy A

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Chinnaseeragapadi

Vinithkumar1403@gmail.com9790243751

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026